Top 10 alxoncology.com Competitors

eurekatherapeutics.com

The first patient with GPC3-positive advanced hepatocellular carcinoma (HCC), the predominant type of liver cancer, was treated with ECT204 T cell therapy.

corvuspharma.com

corvus pharmaceuticals is a clinical science-driven biopharmaceutical company focused on the development of cleverly-designed medicines with precise mechanisms of action to improve the lives of patients with the most difficult-to-treat cancers.

aligos.com

Aligos is dedicated to developing potential new treatments for serious and life-threatening diseases. To accomplish this goal, we must utilize our resources efficiently to focus on advancing our investigational products through the clinical development process. In this way, we are currently prioritizing enrolling and conducting the clinical trials necessary to generate data sufficient to apply […]

astellasgenetherapies.com

Gene Therapy Company | Rare Genetic Disease

titanpharm.com

Titan Pharmaceuticals, Inc. - Privacy Policy

theravance.com

View open positions for creative problems solvers who thrive on applying insight and innovation to discovering and advancing novel medicines. Join the team.

mbcbiolabs.com

December 14, 2017 1. HPLC Products 2. Business Development and Venture Investment Our newest sponsor Tosoh will be here on December 14th. Amongst Tosoh's interests is the Separations and Purification Division.  Their scientist, Philip Hoang, will be here and would be happy to meet with you to

nektar.com

Contact Nektar for partnerships, careers, investor relations, media, clinical trial information, and more.

nurixtx.com

Browse current openings at Nurix across research, clinical, and business roles. Find your next opportunity. We'd love to hear from you.

assemblybio.com

Passionate about making a profound impact on peoples’ lives Assembly Bio is an ambitious biopharmaceutical company with cutting-edge therapeutic candidates capable of improving the lives of millions living with devastating viral diseases. We have multiple ongoing clinical programs focused on the development of novel antivirals to treat herpesviruses, hepatitis delta virus (HDV) and hepatitis B […]